Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation

MLA

Alethea Cope, et al. “Antibody Responses after Intravaginal Immunisation with Trimeric HIV-1CN54 Clade C Gp140 in Carbopol Gel Are Augmented by Systemic Priming or Boosting with an Adjuvanted Formulation.” Vaccine, vol. 29, no. 7, Feb. 2011, pp. 1421–30. EBSCOhost, https://doi.org/10.1016/j.vaccine.2010.12.034.

APA

Alethea Cope, Michael S. Seaman, Tom Cole, Elaine Giles, Martin Cranage, Mark Page, A. Nasir Mahmoud, Paul F. McKay, Robin J. Shattock, Gerald Voss, Joanna Hall, Neil Almond, & C. Fraser. (2011). Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation. Vaccine, 29(7), 1421–1430. https://doi.org/10.1016/j.vaccine.2010.12.034

Chicago

Alethea Cope, Michael S. Seaman, Tom Cole, Elaine Giles, Martin Cranage, Mark Page, A. Nasir Mahmoud, et al. 2011. “Antibody Responses after Intravaginal Immunisation with Trimeric HIV-1CN54 Clade C Gp140 in Carbopol Gel Are Augmented by Systemic Priming or Boosting with an Adjuvanted Formulation.” Vaccine 29 (7): 1421–30. doi:10.1016/j.vaccine.2010.12.034.